On Invalid Date, Lucid Diagnostics (NASDAQ: LUCD) reported Q1 2023 earnings per share (EPS) of -$0.40, up 14.29% year over year. Total Lucid Diagnostics earnings for the quarter were -$16.25 million. In the same quarter last year, Lucid Diagnostics's earnings per share (EPS) was -$0.35.
As of Q2 2023, Lucid Diagnostics's earnings has grown year over year. Lucid Diagnostics's earnings in the past year totalled -$60.15 million.
What was LUCD's revenue last quarter?
On Invalid Date, Lucid Diagnostics (NASDAQ: LUCD) reported Q1 2023 revenue of $446.00 thousand up 135.98% year over year. In the same quarter last year, Lucid Diagnostics's revenue was $189.00 thousand.
What was LUCD's revenue growth in the past year?
As of Q2 2023, Lucid Diagnostics's revenue has grown -7.98% year over year. This is 13.51 percentage points lower than the US Medical Devices industry revenue growth rate of 5.53%. Lucid Diagnostics's revenue in the past year totalled $634.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.